The global market for advanced drug delivery systems (ADDS) is estimated to grow from $299.6 billion in 2025 and projected to reach $487.4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.2% from 2025 to 2030. ![Advanced Drug Delivery Systems Market]( "Advanced Drug Delivery Systems Market")
ADDS are technologies that precisely control the release rate of medication, tailored to specific diseases, drug types and therapeutic effects. These systems have significantly increased the efficiency and effectiveness of treatments, overcoming challenges such as poor solubility and toxicity. They also unlock the value of existing drugs stored in intellectual property vaults due to their inability to be effectively delivered using earlier methods.
Developing and approving new drugs is a long, expensive process with no guarantee of success. Pharmaceutical companies constantly seek better ways to deliver existing compounds to the right biological target. Innovations in science and technology have led to significant advances in drug delivery systems, allowing pharmaceutical companies to capitalize on valuable intellectual property.
The market is segmented by routes of administration into enteral, parenteral, nasal, transdermal, implant, ophthalmic and other routes. Enteral routes are sub-segmented into oral, sublingual, buccal and rectal. Parenteral routes are sub-segmented into intravenous, subcutaneous and intramuscular. The respiratory route is sub-segmented into intranasal and inhalational.
The market is segmented by technology into targeted-release drug delivery, extended-release drug delivery, delayed-release drug delivery, immediate-release drug delivery and pulsatile-release drug delivery. Based on vehicle/carriers, the market scope is segmented into nanoparticles, monoclonal antibodies, liposomes, polymer therapeutics, prodrugs, microparticles and others.
The market is segmented by application into oncological, cardiovascular, respiratory, autoimmune, inflammatory, metabolic, as well as gastrointestinal disorders, ophthalmic and other therapeutics.
The market has been segmented into significant geographical regions: North America, Europe, Asia-Pacific, the Middle East and Africa (MEA) and South America. The regional segment will include a detailed analysis of major countries such as the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia and India. For market estimates, data will be provided for 2024 as the base year, with forecast values for 2025 through 2030.
ADDS are technologies that precisely control the release rate of medication, tailored to specific diseases, drug types and therapeutic effects. These systems have significantly increased the efficiency and effectiveness of treatments, overcoming challenges such as poor solubility and toxicity. They also unlock the value of existing drugs stored in intellectual property vaults due to their inability to be effectively delivered using earlier methods.
Developing and approving new drugs is a long, expensive process with no guarantee of success. Pharmaceutical companies constantly seek better ways to deliver existing compounds to the right biological target. Innovations in science and technology have led to significant advances in drug delivery systems, allowing pharmaceutical companies to capitalize on valuable intellectual property.
Market Dynamics and Growth Factors
The increasing incidence of chronic diseases, nanotechnology in advancing drug delivery, advances in therapeutics and material science, R&D spending by manufacturers, increased government funding and pharmaceutical R&D spending were reviewed to understand the market dynamics and trends for forecasting the market size.Report Scope
The current report provides detailed information on advanced drug delivery systems (ADDS). This report analyzes the market trends of ADDS with data from 2024, estimates for 2025, projections of compound annual growth rates through 2030 (forecast period 2025-2030) and regional markets of advanced drug delivery systems. This report highlights the advanced drug delivery systems’ current and future market potential of ADDS and provides a detailed analysis of the competitive environment. The report covers regulatory scenarios, drivers, restraints and opportunities, as well as market projections for 2030 and the market shares of leading manufacturers.The market is segmented by routes of administration into enteral, parenteral, nasal, transdermal, implant, ophthalmic and other routes. Enteral routes are sub-segmented into oral, sublingual, buccal and rectal. Parenteral routes are sub-segmented into intravenous, subcutaneous and intramuscular. The respiratory route is sub-segmented into intranasal and inhalational.
The market is segmented by technology into targeted-release drug delivery, extended-release drug delivery, delayed-release drug delivery, immediate-release drug delivery and pulsatile-release drug delivery. Based on vehicle/carriers, the market scope is segmented into nanoparticles, monoclonal antibodies, liposomes, polymer therapeutics, prodrugs, microparticles and others.
The market is segmented by application into oncological, cardiovascular, respiratory, autoimmune, inflammatory, metabolic, as well as gastrointestinal disorders, ophthalmic and other therapeutics.
The market has been segmented into significant geographical regions: North America, Europe, Asia-Pacific, the Middle East and Africa (MEA) and South America. The regional segment will include a detailed analysis of major countries such as the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia and India. For market estimates, data will be provided for 2024 as the base year, with forecast values for 2025 through 2030.
The report aims to:
- Analyze types of ADDS.
- Analyze global market size and segmentation.
- Understand market constraints and drivers.
- Provide detailed market forecasts for 2030.
- Assess market shares, competitiveness and industry structure.
- Identify potential long-term impacts on the advanced drug delivery systems market.
The report includes:
- 170 data tables and 79 additional tables
- Overview and an analysis of the global markets and technologies for advanced drug delivery systems (ADDS) with a focus on the routes of administration (RoA)
- In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, as well as forecasts for 2030. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
- Evaluation of the current market size and revenue growth prospects specific to the advanced drug delivery systems, accompanied by a market share analysis by route of administration, technology, application, vehicle/carrier and region
- Analysis of current and future demand in the global advanced drug delivery systems market, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
- Analysis of drivers, challenges and opportunities affecting market growth
- Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios and ESG trends of the market
- Market share analysis of the key market participants in the advanced drug delivery systems market, along with their research priorities, product portfolios, global rankings and company competitive landscape
- Company profiles of the leading global players, including AbbVie Inc., GSK plc, AstraZeneca, Novartis AG, Roche and Johnson & Johnson Services, Inc.
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Market Dynamics and Growth Factors
- Emerging Technologies
- Segmental Analysis
- Regional Analysis
- Conclusion
Chapter 2 Market Overview
- Overview
- Macroeconomic Factors Analysis
- Impact of U.S. Tariffs on the Pharmaceutical Industry
- Healthcare Expenditure
- Aging Population
- Geopolitical Risks, Trade Wars and Supply Chain Disruptions
- Impact of Global Economic Growth (GDP) on the Pharma Sector
- Porter's Five Forces Analysis
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Potential for New Entrants
- Threat of Substitutes
- Competitiveness in the Industry
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Increasing Incidence of Chronic Diseases
- Nanotechnology in Advancing Drug Delivery
- Advances in Therapeutics and Material Science
- Increasing R&D Spending by Companies
- Rise in Government Funding and Pharmaceutical R&D Spending
- Market Restraints
- Route-Specific Barriers
- Limitations with Nanotechnology and Nanoparticles
- Challenges with Nano-drug Delivery
- Market Opportunities
- Cost-Efficiency of Advanced Drug Delivery Systems
- Mechanism of Nanoparticles in Overcoming Drug Resistance
- Emerging Markets
Chapter 4 Regulatory Landscape
- Overview
- The U.S.
- Europe
- Asia-Pacific
Chapter 5 Emerging Technologies and Pipeline Analysis
- Overview
- Artificial Intelligence (AI) and Machine Learning (ML)
- 3D Printing
- Smart Drug Delivery System
- Clinical Trial Analysis
- Clinical Trials Analysis by Type of Study
- Clinical Trials Analysis by Status
- Clinical Trials Analysis by Phase
- Key Takeaways
- Patent Analysis
- Patents, by Leading Applicant
- Patents, by Jurisdiction
- Key Takeaways
Chapter 6 Market Segmentation Analysis
- Segmentation Breakdown
- Global Market for Advanced Drug Delivery Systems, by Route of Administration
- Key Takeaways
- Enteral Routes
- Parenteral Routes
- Respiratory Route
- Transdermal Route
- Implants
- Ophthalmic
- Others
- Global Market for Advanced Drug Delivery Systems, by Technology
- Key Takeaways
- Targeted Release Drug Delivery
- Extended Release Drug Delivery
- Delayed Release Drug Delivery
- Immediate Release Drug Delivery
- Pulsatile Release Drug Delivery
- Global Market for Advanced Drug Delivery Systems, by Vehicle/Carrier
- Key Takeaways
- Nanoparticles
- Monoclonal Antibodies
- Liposomes
- Polymer Therapeutics
- Prodrugs
- Microparticles
- Other Vehicles/Carriers
- Global Market for Advanced Drug Delivery Systems, by Application
- Key Takeaways
- Oncology
- Cardiovascular Diseases
- Respiratory Diseases
- Autoimmune Diseases
- Inflammatory Diseases
- Metabolic Diseases
- Gastrointestinal Disorders
- Ophthalmic
- Other Applications
- Geographic Breakdown
- Global Market for Advanced Drug Delivery Systems, by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- Middle East and Africa (MEA)
- South America
Chapter 7 Competitive Intelligence
- Key Takeaways
- Competitive Landscape
- Company Share Analysis
Chapter 8 Sustainability in the Advanced Drug Delivery Systems Market: An ESG Perspective
- Introduction to ESG
- Sustainability in the Advanced Drug Delivery Systems Market
- ESG Perspective
- Environmental Impact
- Social Impact
- Governance Impact
- ESG Risk Ratings
- Conclusion
Chapter 9 Appendix
- Methodology
- Abbreviations
- Sources
List of Tables
Summary Table: Global Market for Advanced Drug Delivery Systems, by Region, Through 2030
Table 1: Current Health Expenditure, by Country, 2021-2023
Table 2: Rheumatoid Arthritis - Level 3 Cause, 2021
Table 3: Global HIV Epidemic, by Age Group, 2023
Table 4: Global Diabetes Prevalence, Estimates and Projections, 2024-2050
Table 5: National Cancer Institute Funding, by Mechanism, 2020-2024
Table 6: Research Projects Using 3D Printing Techniques to Design Drug Delivery Systems
Table 7: Clinical Trials in Advanced Drug Delivery Systems, by Type of Study, as of September 2025
Table 8: ADDS Clinical Trials, by Status, as of September 2025
Table 9: ADDS Clinical Trials, by Phase, as of September 2025
Table 10: List of Phase IV ADDS Clinical Trials, 2025
Table 11: Patents Granted for Drug Delivery Systems, by Leading Applicant, 2025
Table 12: Patents Granted for Drug Delivery Systems, by Jurisdiction, 2025
Table 13: Global Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 14: Global Market for Enteral Routes in Advanced Drug Delivery Systems, by Region, Through 2030
Table 15: Global Market for Enteral Routes in Advanced Drug Delivery Systems, by Type, Through 2030
Table 16: Oral Route: Market Overview
Table 17: Sublingual and Buccal Route: Market Overview
Table 18: Examples of Clinically Approved Rectal Formulations
Table 19: Rectal Route: Market Overview
Table 20: Vaginal Route: Market Overview
Table 21: Urethral Route: Market Overview
Table 22: Parenteral Routes: Market Overview
Table 23: Global Market for Parenteral Routes in Advanced Drug Delivery Systems, by Region, Through 2030
Table 24: Global Market for Parenteral Routes in Advanced Drug Delivery Systems, by Type, Through 2030
Table 25: Intravenous Routes: Market Overview
Table 26: Subcutaneous Routes: Market Overview
Table 27: Intramuscular Routes: Market Overview
Table 28: Examples of Specialized Parenteral Routes of Administration
Table 29: Respiratory Route: Market Overview
Table 30: Global Market for Respiratory Route in Advanced Drug Delivery Systems, by Region, Through 2030
Table 31: Global Market for Respiratory Routes in Advanced Drug Delivery Systems, by Type, Through 2030
Table 32: Intranasal Route: Market Overview
Table 33: Inhalational Route: Market Overview
Table 34: Transdermal Route: Market Overview
Table 35: Global Market for Transdermal Route in Advanced Drug Delivery Systems, by Region, Through 2030
Table 36: Global Market for Implants in Advanced Drug Delivery Systems, by Region, Through 2030
Table 37: Examples of Ophthalmology Drug Delivery Systems
Table 38: Global Market for Ophthalmic Route in Advanced Drug Delivery Systems, by Region, Through 2030
Table 39: Global Market for Other Routes in Advanced Drug Delivery Systems, by Region, Through 2030
Table 40: Global Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 41: Examples of Delivery Carriers for Targeted Drug Delivery Systems
Table 42: Global Market for Targeted Release Drug Delivery in Advanced Drug Delivery Systems, by Region, Through 2030
Table 43: Sustained vs. Controlled Drug Delivery
Table 44: Global Market for Extended Release Drug Delivery in Advanced Drug Delivery Systems, by Region, Through 2030
Table 45: Global Market for Delayed Release Drug Delivery in Advanced Drug Delivery Systems, by Region, Through 2030
Table 46: Global Market for Immediate Release Drug Delivery in Advanced Drug Delivery Systems, by Region, Through 2030
Table 47: Global Market for Pulsatile Release Drug Delivery in Advanced Drug Delivery Systems, by Region, Through 2030
Table 48: Global Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 49: Examples of Nanocarriers in Drug Delivery and Their Characteristics
Table 50: Global Market for Nanoparticles in Advanced Drug Delivery Systems, by Region, Through 2030
Table 51: Global Market for Monoclonal Antibodies in Advanced Drug Delivery Systems, by Region, Through 2030
Table 52: Global Market for Liposomes in Advanced Drug Delivery Systems, by Region, Through 2030
Table 53: Global Market for Polymer Therapeutics in Advanced Drug Delivery Systems, by Region, Through 2030
Table 54: Global Market for Polymer Therapeutics in Advanced Drug Delivery Systems, by Type, Through 2030
Table 55: Global Market for Prodrugs in Advanced Drug Delivery Systems, by Region, Through 2030
Table 56: Global Market for Microparticles in Advanced Drug Delivery Systems, by Region, Through 2030
Table 57: Global Market for Other Vehicle/Carriers in Advanced Drug Delivery Systems, by Region, Through 2030
Table 58: Global Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 59: Global Market for Advanced Drug Delivery System in Oncology, by Region, Through 2030
Table 60: Examples of Systems Used in the Cardiovascular Delivery of Therapeutics
Table 61: Global Market for Advanced Drug Delivery Systems in Cardiovascular Diseases, by Region, Through 2030
Table 62: Global Market for Advanced Drug Delivery Systems in Respiratory Diseases, by Region, Through 2030
Table 63: Global Market for Advanced Drug Delivery Systems in Autoimmune Diseases, by Region, Through 2030
Table 64: Global Market for Advanced Drug Delivery Systems in Inflammatory Diseases, by Region, Through 2030
Table 65: Global Market for Advanced Drug Delivery Systems in Metabolic Diseases, by Region, Through 2030
Table 66: Global Market for Advanced Drug Delivery Systems in Gastrointestinal Disorders, by Region, Through 2030
Table 67: Global Market for Advanced Drug Delivery Systems in Ophthalmic Applications, by Region, Through 2030
Table 68: Global Market for Advanced Drug Delivery Systems in Other Diseases, by Region, Through 2030
Table 69: Global Market for Advanced Drug Delivery Systems, by Region, Through 2030
Table 70: North American Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 71: North American Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 72: North American Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 73: North American Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 74: North American Market for Advanced Drug Delivery Systems, by Country, Through 2030
Table 75: U.S. Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 76: U.S. Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 77: U.S. Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 78: U.S. Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 79: Canadian Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 80: Canadian Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 81: Canadian Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 82: Canadian Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 83: Mexican Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 84: Mexican Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 85: Mexican Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 86: Mexican Market for Advanced Drug Delivery System, by Application, Through 2030
Table 87: European Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 88: European Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 89: European Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 90: European Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 91: European Market for Advanced Drug Delivery Systems, by Country, Through 2030
Table 92: German Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 93: German Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 94: German Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 95: German Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 96: U.K. Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 97: U.K. Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 98: U.K. Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 99: U.K. Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 100: French Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 101: French Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 102: French Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 103: French Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 104: Italian Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 105: Italian Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 106: Italian Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 107: Italian Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 108: Spanish Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 109: Spanish Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 110: Spanish Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 111: Spanish Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 112: Rest of Europe Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 113: Rest of Europe Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 114: Rest of Europe Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 115: Rest of Europe Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 116: Asia-Pacific Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 117: Asia-Pacific Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 118: Asia-Pacific Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 119: Asia-Pacific Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 120: Asia-Pacific Market for Advanced Drug Delivery Systems, by Country, Through 2030
Table 121: Chinese Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 122: Chinese Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 123: Chinese Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 124: Chinese Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 125: Japanese Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 126: Japanese Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 127: Japanese Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 128: Japanese Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 129: Indian Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 130: Indian Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 131: Indian Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 132: Indian Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 133: South Korean Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 134: South Korean Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 135: South Korean Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 136: South Korean Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 137: Australian Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 138: Australian Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 139: Australian Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 140: Australian Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 141: Rest of Asia-Pacific Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 142: Rest of Asia-Pacific Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 143: Rest of Asia-Pacific Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 144: Rest of Asia-Pacific Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 145: MEA Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 146: MEA Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 147: MEA Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 148: MEA Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 149: MEA Market for Advanced Drug Delivery Systems, by Sub-Region, Through 2030
Table 150: Middle East Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 151: Middle East Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 152: Middle East Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 153: Middle East Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 154: African Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 155: African Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 156: African Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 157: African Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 158: South American Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 159: South American Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 160: South American Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 161: South American Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 162: South American Market for Advanced Drug Delivery Systems, by Country, Through 2030
Table 163: Brazilian Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 164: Brazilian Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 165: Brazilian Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 166: Brazilian Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 167: Argentinian Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 168: Argentinian Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 169: Argentinian Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 170: Argentinian Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 171: Rest of South America Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 172: Rest of South America Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 173: Rest of South America Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 174: Rest of South America Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 175: Key Strategic Initiatives in the Advanced Drug Delivery Systems Market, 2024-2025
Table 176: Key Focus Areas in ESG Metrics
Table 177: ESG Rankings for Leading Companies in the Advanced Drug Delivery Systems Market, 2025*
Table 178: Abbreviations Used in this Report
Table 179: Information Sources for This Report
Table 180: Abbott: Company Snapshot
Table 181: Abbott: Financial Performance, FY 2023 and 2024
Table 182: Abbott: Product Portfolio
Table 183: Abbott: News/Key Developments, 2024
Table 184: AbbVie Inc.: Company Snapshot
Table 185: AbbVie Inc.: Financial Performance, FY 2023 and 2024
Table 186: AbbVie Inc.: Product Portfolio
Table 187: AbbVie Inc.: News/Key Developments, 2023-2025
Table 188: Amgen Inc.: Company Snapshot
Table 189: Amgen Inc.: Financial Performance, FY 2023 and 2024
Table 190: Amgen Inc.: Product Portfolio
Table 191: Amgen Inc.: News/Key Developments, 2022-2023
Table 192: AstraZeneca: Company Snapshot
Table 193: AstraZeneca: Financial Performance, FY 2023 and 2024
Table 194: AstraZeneca: Product Portfolio
Table 195: AstraZeneca: News/Recent Developments, 2023-2025
Table 196: Baxter: Company Snapshot
Table 197: Baxter: Financial Performance, FY 2023 and 2024
Table 198: Baxter: Product Portfolio
Table 199: Baxter: News/Key Developments, 2021
Table 200: Bayer AG: Company Snapshot
Table 201: Bayer AG: Financial Performance, FY 2023 and 2024
Table 202: Bayer AG: Product Portfolio
Table 203: Bayer AG: News/Key Developments, 2022
Table 204: Boston Scientific Corp.: Company Snapshot
Table 205: Boston Scientific Corp.: Financial Performance, FY 2023 and 2024
Table 206: Boston Scientific Corp.: Product Portfolio
Table 207: Boston Scientific Corp.: News/Key Developments, 2024-2025
Table 208: Bristol-Myers Squibb Co.: Company Snapshot
Table 209: Bristol-Myers Squibb Co.: Financial Performance, FY 2022 and 2024
Table 210: Bristol-Myers Squibb Co.: Product Portfolio
Table 211: Bristol-Myers Squibb Co.: News/Key Developments, 2023-2025
Table 212: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 213: F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2023 and 2024
Table 214: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 215: F. Hoffmann-La Roche Ltd.: News/Key Developments, 2023-2025
Table 216: Gilead Sciences Inc.: Company Snapshot
Table 217: Gilead Sciences Inc.: Financial Performance, FY 2023 and 2024
Table 218: Gilead Sciences Inc.: Product Portfolio
Table 219: Gilead Sciences Inc.: News/Key Developments, 2023-2025
Table 220: GSK plc: Company Snapshot
Table 221: GSK plc: Financial Performance, FY 2023 and 2024
Table 222: GSK plc: Product Portfolio
Table 223: GSK plc: News/Key Developments, 2022-2025
Table 224: Jazz Pharmaceuticals Inc.: Company Snapshot
Table 225: Jazz Pharmaceuticals Inc.: Financial Performance, FY 2023 and 2024
Table 226: Jazz Pharmaceuticals Inc.: Product Portfolio
Table 227: Jazz Pharmaceuticals Inc.: News/Key Developments, 2024-2025
Table 228: Johnson & Johnson: Company Snapshot
Table 229: Johnson & Johnson: Financial Performance, FY 2023 and 2024
Table 230: Johnson & Johnson Services Inc.: Product Portfolio
Table 231: Johnson & Johnson: News/Key Developments, 2022-2025
Table 232: Merck & Co. Inc.: Company Snapshot
Table 233: Merck & Co. Inc.: Financial Performance, FY 2023 and 2024
Table 234: Merck & Co. Inc.: Product Portfolio
Table 235: Merck & Co. Inc.: News/Key Developments, 2025
Table 236: Novartis AG: Company Snapshot
Table 237: Novartis AG: Financial Performance, FY 2023 and 2024
Table 238: Novartis AG: Product Portfolio
Table 239: Novartis AG: News/Key Developments, 2022-2025
Table 240: Pfizer Inc.: Company Snapshot
Table 241: Pfizer Inc.: Financial Performance, FY 2023 and 2024
Table 242: Pfizer Inc.: Product Portfolio
Table 243: Pfizer Inc.: News/Key Developments, 2023-2025
Table 244: Sanofi: Company Snapshot
Table 245: Sanofi: Financial Performance, FY 2023 and 2024
Table 246: Sanofi: Product Portfolio
Table 247: Sanofi: News/Key Developments, 2022-2024
Table 248: A Few Emerging Companies in the Advanced Drug Delivery Systems Market
Table 1: Current Health Expenditure, by Country, 2021-2023
Table 2: Rheumatoid Arthritis - Level 3 Cause, 2021
Table 3: Global HIV Epidemic, by Age Group, 2023
Table 4: Global Diabetes Prevalence, Estimates and Projections, 2024-2050
Table 5: National Cancer Institute Funding, by Mechanism, 2020-2024
Table 6: Research Projects Using 3D Printing Techniques to Design Drug Delivery Systems
Table 7: Clinical Trials in Advanced Drug Delivery Systems, by Type of Study, as of September 2025
Table 8: ADDS Clinical Trials, by Status, as of September 2025
Table 9: ADDS Clinical Trials, by Phase, as of September 2025
Table 10: List of Phase IV ADDS Clinical Trials, 2025
Table 11: Patents Granted for Drug Delivery Systems, by Leading Applicant, 2025
Table 12: Patents Granted for Drug Delivery Systems, by Jurisdiction, 2025
Table 13: Global Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 14: Global Market for Enteral Routes in Advanced Drug Delivery Systems, by Region, Through 2030
Table 15: Global Market for Enteral Routes in Advanced Drug Delivery Systems, by Type, Through 2030
Table 16: Oral Route: Market Overview
Table 17: Sublingual and Buccal Route: Market Overview
Table 18: Examples of Clinically Approved Rectal Formulations
Table 19: Rectal Route: Market Overview
Table 20: Vaginal Route: Market Overview
Table 21: Urethral Route: Market Overview
Table 22: Parenteral Routes: Market Overview
Table 23: Global Market for Parenteral Routes in Advanced Drug Delivery Systems, by Region, Through 2030
Table 24: Global Market for Parenteral Routes in Advanced Drug Delivery Systems, by Type, Through 2030
Table 25: Intravenous Routes: Market Overview
Table 26: Subcutaneous Routes: Market Overview
Table 27: Intramuscular Routes: Market Overview
Table 28: Examples of Specialized Parenteral Routes of Administration
Table 29: Respiratory Route: Market Overview
Table 30: Global Market for Respiratory Route in Advanced Drug Delivery Systems, by Region, Through 2030
Table 31: Global Market for Respiratory Routes in Advanced Drug Delivery Systems, by Type, Through 2030
Table 32: Intranasal Route: Market Overview
Table 33: Inhalational Route: Market Overview
Table 34: Transdermal Route: Market Overview
Table 35: Global Market for Transdermal Route in Advanced Drug Delivery Systems, by Region, Through 2030
Table 36: Global Market for Implants in Advanced Drug Delivery Systems, by Region, Through 2030
Table 37: Examples of Ophthalmology Drug Delivery Systems
Table 38: Global Market for Ophthalmic Route in Advanced Drug Delivery Systems, by Region, Through 2030
Table 39: Global Market for Other Routes in Advanced Drug Delivery Systems, by Region, Through 2030
Table 40: Global Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 41: Examples of Delivery Carriers for Targeted Drug Delivery Systems
Table 42: Global Market for Targeted Release Drug Delivery in Advanced Drug Delivery Systems, by Region, Through 2030
Table 43: Sustained vs. Controlled Drug Delivery
Table 44: Global Market for Extended Release Drug Delivery in Advanced Drug Delivery Systems, by Region, Through 2030
Table 45: Global Market for Delayed Release Drug Delivery in Advanced Drug Delivery Systems, by Region, Through 2030
Table 46: Global Market for Immediate Release Drug Delivery in Advanced Drug Delivery Systems, by Region, Through 2030
Table 47: Global Market for Pulsatile Release Drug Delivery in Advanced Drug Delivery Systems, by Region, Through 2030
Table 48: Global Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 49: Examples of Nanocarriers in Drug Delivery and Their Characteristics
Table 50: Global Market for Nanoparticles in Advanced Drug Delivery Systems, by Region, Through 2030
Table 51: Global Market for Monoclonal Antibodies in Advanced Drug Delivery Systems, by Region, Through 2030
Table 52: Global Market for Liposomes in Advanced Drug Delivery Systems, by Region, Through 2030
Table 53: Global Market for Polymer Therapeutics in Advanced Drug Delivery Systems, by Region, Through 2030
Table 54: Global Market for Polymer Therapeutics in Advanced Drug Delivery Systems, by Type, Through 2030
Table 55: Global Market for Prodrugs in Advanced Drug Delivery Systems, by Region, Through 2030
Table 56: Global Market for Microparticles in Advanced Drug Delivery Systems, by Region, Through 2030
Table 57: Global Market for Other Vehicle/Carriers in Advanced Drug Delivery Systems, by Region, Through 2030
Table 58: Global Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 59: Global Market for Advanced Drug Delivery System in Oncology, by Region, Through 2030
Table 60: Examples of Systems Used in the Cardiovascular Delivery of Therapeutics
Table 61: Global Market for Advanced Drug Delivery Systems in Cardiovascular Diseases, by Region, Through 2030
Table 62: Global Market for Advanced Drug Delivery Systems in Respiratory Diseases, by Region, Through 2030
Table 63: Global Market for Advanced Drug Delivery Systems in Autoimmune Diseases, by Region, Through 2030
Table 64: Global Market for Advanced Drug Delivery Systems in Inflammatory Diseases, by Region, Through 2030
Table 65: Global Market for Advanced Drug Delivery Systems in Metabolic Diseases, by Region, Through 2030
Table 66: Global Market for Advanced Drug Delivery Systems in Gastrointestinal Disorders, by Region, Through 2030
Table 67: Global Market for Advanced Drug Delivery Systems in Ophthalmic Applications, by Region, Through 2030
Table 68: Global Market for Advanced Drug Delivery Systems in Other Diseases, by Region, Through 2030
Table 69: Global Market for Advanced Drug Delivery Systems, by Region, Through 2030
Table 70: North American Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 71: North American Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 72: North American Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 73: North American Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 74: North American Market for Advanced Drug Delivery Systems, by Country, Through 2030
Table 75: U.S. Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 76: U.S. Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 77: U.S. Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 78: U.S. Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 79: Canadian Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 80: Canadian Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 81: Canadian Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 82: Canadian Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 83: Mexican Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 84: Mexican Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 85: Mexican Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 86: Mexican Market for Advanced Drug Delivery System, by Application, Through 2030
Table 87: European Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 88: European Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 89: European Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 90: European Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 91: European Market for Advanced Drug Delivery Systems, by Country, Through 2030
Table 92: German Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 93: German Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 94: German Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 95: German Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 96: U.K. Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 97: U.K. Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 98: U.K. Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 99: U.K. Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 100: French Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 101: French Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 102: French Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 103: French Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 104: Italian Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 105: Italian Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 106: Italian Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 107: Italian Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 108: Spanish Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 109: Spanish Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 110: Spanish Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 111: Spanish Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 112: Rest of Europe Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 113: Rest of Europe Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 114: Rest of Europe Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 115: Rest of Europe Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 116: Asia-Pacific Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 117: Asia-Pacific Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 118: Asia-Pacific Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 119: Asia-Pacific Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 120: Asia-Pacific Market for Advanced Drug Delivery Systems, by Country, Through 2030
Table 121: Chinese Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 122: Chinese Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 123: Chinese Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 124: Chinese Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 125: Japanese Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 126: Japanese Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 127: Japanese Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 128: Japanese Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 129: Indian Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 130: Indian Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 131: Indian Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 132: Indian Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 133: South Korean Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 134: South Korean Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 135: South Korean Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 136: South Korean Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 137: Australian Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 138: Australian Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 139: Australian Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 140: Australian Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 141: Rest of Asia-Pacific Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 142: Rest of Asia-Pacific Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 143: Rest of Asia-Pacific Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 144: Rest of Asia-Pacific Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 145: MEA Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 146: MEA Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 147: MEA Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 148: MEA Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 149: MEA Market for Advanced Drug Delivery Systems, by Sub-Region, Through 2030
Table 150: Middle East Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 151: Middle East Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 152: Middle East Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 153: Middle East Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 154: African Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 155: African Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 156: African Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 157: African Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 158: South American Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 159: South American Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 160: South American Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 161: South American Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 162: South American Market for Advanced Drug Delivery Systems, by Country, Through 2030
Table 163: Brazilian Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 164: Brazilian Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 165: Brazilian Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 166: Brazilian Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 167: Argentinian Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 168: Argentinian Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 169: Argentinian Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 170: Argentinian Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 171: Rest of South America Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 172: Rest of South America Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 173: Rest of South America Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 174: Rest of South America Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 175: Key Strategic Initiatives in the Advanced Drug Delivery Systems Market, 2024-2025
Table 176: Key Focus Areas in ESG Metrics
Table 177: ESG Rankings for Leading Companies in the Advanced Drug Delivery Systems Market, 2025*
Table 178: Abbreviations Used in this Report
Table 179: Information Sources for This Report
Table 180: Abbott: Company Snapshot
Table 181: Abbott: Financial Performance, FY 2023 and 2024
Table 182: Abbott: Product Portfolio
Table 183: Abbott: News/Key Developments, 2024
Table 184: AbbVie Inc.: Company Snapshot
Table 185: AbbVie Inc.: Financial Performance, FY 2023 and 2024
Table 186: AbbVie Inc.: Product Portfolio
Table 187: AbbVie Inc.: News/Key Developments, 2023-2025
Table 188: Amgen Inc.: Company Snapshot
Table 189: Amgen Inc.: Financial Performance, FY 2023 and 2024
Table 190: Amgen Inc.: Product Portfolio
Table 191: Amgen Inc.: News/Key Developments, 2022-2023
Table 192: AstraZeneca: Company Snapshot
Table 193: AstraZeneca: Financial Performance, FY 2023 and 2024
Table 194: AstraZeneca: Product Portfolio
Table 195: AstraZeneca: News/Recent Developments, 2023-2025
Table 196: Baxter: Company Snapshot
Table 197: Baxter: Financial Performance, FY 2023 and 2024
Table 198: Baxter: Product Portfolio
Table 199: Baxter: News/Key Developments, 2021
Table 200: Bayer AG: Company Snapshot
Table 201: Bayer AG: Financial Performance, FY 2023 and 2024
Table 202: Bayer AG: Product Portfolio
Table 203: Bayer AG: News/Key Developments, 2022
Table 204: Boston Scientific Corp.: Company Snapshot
Table 205: Boston Scientific Corp.: Financial Performance, FY 2023 and 2024
Table 206: Boston Scientific Corp.: Product Portfolio
Table 207: Boston Scientific Corp.: News/Key Developments, 2024-2025
Table 208: Bristol-Myers Squibb Co.: Company Snapshot
Table 209: Bristol-Myers Squibb Co.: Financial Performance, FY 2022 and 2024
Table 210: Bristol-Myers Squibb Co.: Product Portfolio
Table 211: Bristol-Myers Squibb Co.: News/Key Developments, 2023-2025
Table 212: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 213: F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2023 and 2024
Table 214: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 215: F. Hoffmann-La Roche Ltd.: News/Key Developments, 2023-2025
Table 216: Gilead Sciences Inc.: Company Snapshot
Table 217: Gilead Sciences Inc.: Financial Performance, FY 2023 and 2024
Table 218: Gilead Sciences Inc.: Product Portfolio
Table 219: Gilead Sciences Inc.: News/Key Developments, 2023-2025
Table 220: GSK plc: Company Snapshot
Table 221: GSK plc: Financial Performance, FY 2023 and 2024
Table 222: GSK plc: Product Portfolio
Table 223: GSK plc: News/Key Developments, 2022-2025
Table 224: Jazz Pharmaceuticals Inc.: Company Snapshot
Table 225: Jazz Pharmaceuticals Inc.: Financial Performance, FY 2023 and 2024
Table 226: Jazz Pharmaceuticals Inc.: Product Portfolio
Table 227: Jazz Pharmaceuticals Inc.: News/Key Developments, 2024-2025
Table 228: Johnson & Johnson: Company Snapshot
Table 229: Johnson & Johnson: Financial Performance, FY 2023 and 2024
Table 230: Johnson & Johnson Services Inc.: Product Portfolio
Table 231: Johnson & Johnson: News/Key Developments, 2022-2025
Table 232: Merck & Co. Inc.: Company Snapshot
Table 233: Merck & Co. Inc.: Financial Performance, FY 2023 and 2024
Table 234: Merck & Co. Inc.: Product Portfolio
Table 235: Merck & Co. Inc.: News/Key Developments, 2025
Table 236: Novartis AG: Company Snapshot
Table 237: Novartis AG: Financial Performance, FY 2023 and 2024
Table 238: Novartis AG: Product Portfolio
Table 239: Novartis AG: News/Key Developments, 2022-2025
Table 240: Pfizer Inc.: Company Snapshot
Table 241: Pfizer Inc.: Financial Performance, FY 2023 and 2024
Table 242: Pfizer Inc.: Product Portfolio
Table 243: Pfizer Inc.: News/Key Developments, 2023-2025
Table 244: Sanofi: Company Snapshot
Table 245: Sanofi: Financial Performance, FY 2023 and 2024
Table 246: Sanofi: Product Portfolio
Table 247: Sanofi: News/Key Developments, 2022-2024
Table 248: A Few Emerging Companies in the Advanced Drug Delivery Systems Market
List of Figures
Summary Figure: Global Market Shares for Advanced Drug Delivery Systems, by Region, 2024
Figure 1: Conventional vs. Advanced Drug Delivery
Figure 2: Porter’s Five Forces Analysis of the ADDS Market
Figure 3: Market Dynamics of Advanced Drug Delivery Systems
Figure 4: Global Shares for Most Frequent Cancer Cases in Women,* by Type, 2022
Figure 5: Global Shares for Most Frequent Cancer Cases in Men,* by Type, 2022
Figure 6: Estimated New Cancer Cases and Deaths in the U.S., by Cancer Type, in 2024
Figure 7: Global Shares for Company's Pharmaceutical R&D Expenditures, by Function, 2022
Figure 8: Global Pharmaceutical R&D Spending and Growth, 2020-2026
Figure 9: Global Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 10: Global Market Shares for Enteral Routes in Advanced Drug Delivery Systems, by Region, 2024
Figure 11: Global Market Shares for Enteral Routes in Advanced Drug Delivery Systems, by Type, 2024
Figure 12: Global Market Shares for Parenteral Routes in Advanced Drug Delivery Systems, by Region, 2024
Figure 13: Global Market Shares for Parenteral Routes in Advanced Drug Delivery Systems, by Type, 2024
Figure 14: Global Market Shares for Respiratory Routes in Advanced Drug Delivery Systems, by Region, 2024
Figure 15: Global Market Shares for Respiratory Routes in Advanced Drug Delivery Systems, by Type, 2024
Figure 16: Global Market Shares for Transdermal Route in Advanced Drug Delivery Systems, by Region, 2024
Figure 17: Global Market Shares for Implants in Advanced Drug Delivery Systems, by Region, 2024
Figure 18: Global Market Shares for Ophthalmic Route in Advanced Drug Delivery Systems, by Region, 2024
Figure 19: Global Market Shares for Other Routes in Advanced Drug Delivery Systems, by Region, 2024
Figure 20: Global Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 21: Global Market Shares for Targeted Release Drug Delivery in Advanced Drug Delivery Systems, by Region, 2024
Figure 22: Global Market Shares for Extended Release Drug Delivery in Advanced Drug Delivery Systems, by Region, 2024
Figure 23: Global Market Shares for Delayed Release Drug Delivery in Advanced Drug Delivery Systems, by Region, 2024
Figure 24: Global Market Shares for Immediate Release Drug Delivery in Advanced Drug Delivery Systems, by Region, 2024
Figure 25: Global Market Shares for Pulsatile Release Drug Delivery in Advanced Drug Delivery Systems, by Region, 2024
Figure 26: Global Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 27: Global Market Shares for Nanoparticles in Advanced Drug Delivery Systems, by Region, 2024
Figure 28: Global Market Shares for Monoclonal Antibodies in Advanced Drug Delivery Systems, by Region, 2024
Figure 29: Global Market Shares for Liposomes in Advanced Drug Delivery Systems, by Region, 2024
Figure 30: Global Market Shares for Polymer Therapeutics in Advanced Drug Delivery Systems, by Region, 2024
Figure 31: Global Market Shares for Prodrugs in Advanced Drug Delivery Systems, by Region, 2024
Figure 32: Global Market Shares for Microparticles in Advanced Drug Delivery Systems, by Region, 2024
Figure 33: Global Market Shares for Other Vehicle/Carrier in Advanced Drug Delivery Systems, by Region, 2024
Figure 34: Global Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 35: Global Market Shares for Advanced Drug Delivery Systems in Oncology, by Region, 2024
Figure 36: Global Market Shares for Advanced Drug Delivery Systems in Cardiovascular Diseases, by Region, 2024
Figure 37: Global Market Shares for Advanced Drug Delivery Systems in Respiratory Diseases, by Region, 2024
Figure 38: Global Market Shares for Advanced Drug Delivery Systems in Autoimmune Diseases, by Region, 2024
Figure 39: Global Market Shares for Advanced Drug Delivery Systems in Inflammatory Diseases, by Region, 2024
Figure 40: Global Market Shares for Advanced Drug Delivery Systems in Metabolic Diseases, by Region, 2024
Figure 41: Global Market Shares for Advanced Drug Delivery Systems in Gastrointestinal Disorders, by Region, 2024
Figure 42: Global Market Shares for Advanced Drug Delivery Systems in Ophthalmic Applications, by Region, 2024
Figure 43: Global Market Shares for Advanced Drug Delivery Systems in Other Diseases, by Region, 2024
Figure 44: Global Market Shares for Advanced Drug Delivery Systems, by Region, 2024
Figure 45: North American Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 46: North American Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 47: North American Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 48: North American Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 49: North American Market Shares for Advanced Drug Delivery Systems, by Country, 2024
Figure 50: U.S. Market Shares for Advanced Delivery Systems, by Route of Administration, 2024
Figure 51: U.S. Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 52: U.S. Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 53: U.S. Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 54: Canadian Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 55: Canadian Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 56: Canadian Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 57: Canadian Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 58: Mexican Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 59: Mexican Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 60: Mexican Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 61: Mexican Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 62: European Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 63: European Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 64: European Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 65: European Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 66: European Market Shares for Advanced Drug Delivery Systems, by Country, 2024
Figure 67: German Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 68: German Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 69: German Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 70: German Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 71: U.K. Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 72: U.K. Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 73: U.K. Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 74: U.K. Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 75: French Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 76: French Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 77: French Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 78: French Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 79: Italian Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 80: Italian Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 81: Italian Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 82: Italian Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 83: Spanish Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 84: Spanish Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 85: Spanish Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 86: Spanish Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 87: Rest of Europe Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 88: Rest of Europe Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 89: Rest of Europe Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 90: Rest of Europe Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 91: Asia-Pacific Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 92: Asia-Pacific Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 93: Asia-Pacific Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 94: Asia-Pacific Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 95: Asia-Pacific Market Shares for Advanced Drug Delivery Systems, by Country, 2024
Figure 96: Chinese Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 97: Chinese Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 98: Chinese Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 99: Chinese Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 100: Japanese Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 101: Japanese Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 102: Japanese Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 103: Japanese Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 104: Indian Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 105: Indian Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 106: Indian Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 107: Indian Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 108: South Korean Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 109: South Korean Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 110: South Korean Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 111: South Korean Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 112: Australian Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 113: Australian Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 114: Australian Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 115: Australian Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 116: Rest of Asia-Pacific Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 117: Rest of Asia-Pacific Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 118: Rest of Asia-Pacific Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 119: Rest of Asia-Pacific Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 120: MEA Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 121: MEA Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 122: MEA Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 123: MEA Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 124: MEA Market Shares for Advanced Drug Delivery Systems, by Sub-Region, 2024
Figure 125: Middle East Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 126: Middle East Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 127: Middle East Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 128: Middle East Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 129: African Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 130: African Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 131: African Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 132: African Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 133: South American Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 134: South American Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 135: South American Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 136: South American Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 137: South American Market Shares for Advanced Drug Delivery Systems, by Country, 2024
Figure 138: Brazilian Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 139: Brazilian Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 140: Brazilian Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 141: Brazilian Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 142: Argentinian Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 143: Argentinian Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 144: Argentinian Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 145: Argentinian Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 146: Rest of South America Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 147: Rest of South America Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 148: Rest of South America Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 149: Rest of South America Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 150: Leading 10 Advanced Drug Delivery Systems, by Sales Revenue, 2023-2024
Figure 151: Global Market Shares for Advanced Drug Delivery Systems, by Company, 2024
Figure 152: Pillars of ESG
Figure 153: Advantages of ESG for Companies
Figure 154: Abbott: Revenue Share, by Business Unit, FY 2024
Figure 155: Abbott: Revenue Share, by Country/Region, FY 2024
Figure 156: AbbVie Inc.: Revenue Share, by Business Unit, FY 2024
Figure 157: AbbVie Inc.: Revenue Share, by Country/Region, FY 2024
Figure 158: Amgen Inc.: Revenue Share, by Business Unit, FY 2024
Figure 159: Amgen Inc.: Revenue Share, by Country/Region, FY 2024
Figure 160: AstraZeneca: Revenue Share, by Business Unit, FY 2024
Figure 161: AstraZeneca: Revenue Share, by Country/Region, FY 2024
Figure 162: Baxter: Revenue Share, by Business Unit, FY 2024
Figure 163: Baxter: Revenue Share, by Country/Region, FY 2024
Figure 164: Bayer AG: Revenue Share, by Business Unit, FY 2024
Figure 165: Bayer AG: Revenue Share, by Country/Region, FY 2024
Figure 166: Boston Scientific Corp.: Revenue Share, by Business Unit, FY 2024
Figure 167: Boston Scientific Corp.: Revenue Share, by Country/Region, FY 2024
Figure 168: Bristol-Myers Squibb Co.: Revenue Share, by Business Unit, FY 2024
Figure 169: Bristol-Myers Squibb Co.: Revenue Share, by Country/Region, FY 2024
Figure 170: F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2024
Figure 171: F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2024
Figure 172: Gilead Sciences Inc.: Revenue Share, by Business Unit, FY 2024
Figure 173: Gilead Sciences Inc.: Revenue Share, by Country/Region, FY 2024
Figure 174: GSK plc: Revenue Share, by Business Unit, FY 2024
Figure 175: GSK plc: Revenue Share, by Country/Region, FY 2024
Figure 176: Jazz Pharmaceuticals Inc.: Revenue Share, by Business Unit, FY 2024
Figure 177: Jazz Pharmaceuticals Inc.: Revenue Share, by Country/Region, FY 2024
Figure 178: Johnson & Johnson: Revenue Share, by Business Unit, FY 2024
Figure 179: Johnson & Johnson: Revenue Share, by Country/Region, FY 2024
Figure 180: Merck & Co. Inc.: Revenue Share, by Business Unit, FY 2024
Figure 181: Merck & Co. Inc.: Revenue Share, by Country/Region, FY 2024
Figure 182: Novartis AG: Revenue Share, by Business Unit, FY 2024
Figure 183: Novartis AG: Revenue Share, by Country/Region, FY 2024
Figure 184: Pfizer Inc.: Revenue Share, by Business Unit, FY 2024
Figure 185: Pfizer Inc.: Revenue Share, by Country/Region, FY 2024
Figure 186: Sanofi: Revenue Share, by Country/Region, FY 2024
Figure 1: Conventional vs. Advanced Drug Delivery
Figure 2: Porter’s Five Forces Analysis of the ADDS Market
Figure 3: Market Dynamics of Advanced Drug Delivery Systems
Figure 4: Global Shares for Most Frequent Cancer Cases in Women,* by Type, 2022
Figure 5: Global Shares for Most Frequent Cancer Cases in Men,* by Type, 2022
Figure 6: Estimated New Cancer Cases and Deaths in the U.S., by Cancer Type, in 2024
Figure 7: Global Shares for Company's Pharmaceutical R&D Expenditures, by Function, 2022
Figure 8: Global Pharmaceutical R&D Spending and Growth, 2020-2026
Figure 9: Global Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 10: Global Market Shares for Enteral Routes in Advanced Drug Delivery Systems, by Region, 2024
Figure 11: Global Market Shares for Enteral Routes in Advanced Drug Delivery Systems, by Type, 2024
Figure 12: Global Market Shares for Parenteral Routes in Advanced Drug Delivery Systems, by Region, 2024
Figure 13: Global Market Shares for Parenteral Routes in Advanced Drug Delivery Systems, by Type, 2024
Figure 14: Global Market Shares for Respiratory Routes in Advanced Drug Delivery Systems, by Region, 2024
Figure 15: Global Market Shares for Respiratory Routes in Advanced Drug Delivery Systems, by Type, 2024
Figure 16: Global Market Shares for Transdermal Route in Advanced Drug Delivery Systems, by Region, 2024
Figure 17: Global Market Shares for Implants in Advanced Drug Delivery Systems, by Region, 2024
Figure 18: Global Market Shares for Ophthalmic Route in Advanced Drug Delivery Systems, by Region, 2024
Figure 19: Global Market Shares for Other Routes in Advanced Drug Delivery Systems, by Region, 2024
Figure 20: Global Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 21: Global Market Shares for Targeted Release Drug Delivery in Advanced Drug Delivery Systems, by Region, 2024
Figure 22: Global Market Shares for Extended Release Drug Delivery in Advanced Drug Delivery Systems, by Region, 2024
Figure 23: Global Market Shares for Delayed Release Drug Delivery in Advanced Drug Delivery Systems, by Region, 2024
Figure 24: Global Market Shares for Immediate Release Drug Delivery in Advanced Drug Delivery Systems, by Region, 2024
Figure 25: Global Market Shares for Pulsatile Release Drug Delivery in Advanced Drug Delivery Systems, by Region, 2024
Figure 26: Global Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 27: Global Market Shares for Nanoparticles in Advanced Drug Delivery Systems, by Region, 2024
Figure 28: Global Market Shares for Monoclonal Antibodies in Advanced Drug Delivery Systems, by Region, 2024
Figure 29: Global Market Shares for Liposomes in Advanced Drug Delivery Systems, by Region, 2024
Figure 30: Global Market Shares for Polymer Therapeutics in Advanced Drug Delivery Systems, by Region, 2024
Figure 31: Global Market Shares for Prodrugs in Advanced Drug Delivery Systems, by Region, 2024
Figure 32: Global Market Shares for Microparticles in Advanced Drug Delivery Systems, by Region, 2024
Figure 33: Global Market Shares for Other Vehicle/Carrier in Advanced Drug Delivery Systems, by Region, 2024
Figure 34: Global Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 35: Global Market Shares for Advanced Drug Delivery Systems in Oncology, by Region, 2024
Figure 36: Global Market Shares for Advanced Drug Delivery Systems in Cardiovascular Diseases, by Region, 2024
Figure 37: Global Market Shares for Advanced Drug Delivery Systems in Respiratory Diseases, by Region, 2024
Figure 38: Global Market Shares for Advanced Drug Delivery Systems in Autoimmune Diseases, by Region, 2024
Figure 39: Global Market Shares for Advanced Drug Delivery Systems in Inflammatory Diseases, by Region, 2024
Figure 40: Global Market Shares for Advanced Drug Delivery Systems in Metabolic Diseases, by Region, 2024
Figure 41: Global Market Shares for Advanced Drug Delivery Systems in Gastrointestinal Disorders, by Region, 2024
Figure 42: Global Market Shares for Advanced Drug Delivery Systems in Ophthalmic Applications, by Region, 2024
Figure 43: Global Market Shares for Advanced Drug Delivery Systems in Other Diseases, by Region, 2024
Figure 44: Global Market Shares for Advanced Drug Delivery Systems, by Region, 2024
Figure 45: North American Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 46: North American Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 47: North American Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 48: North American Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 49: North American Market Shares for Advanced Drug Delivery Systems, by Country, 2024
Figure 50: U.S. Market Shares for Advanced Delivery Systems, by Route of Administration, 2024
Figure 51: U.S. Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 52: U.S. Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 53: U.S. Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 54: Canadian Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 55: Canadian Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 56: Canadian Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 57: Canadian Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 58: Mexican Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 59: Mexican Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 60: Mexican Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 61: Mexican Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 62: European Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 63: European Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 64: European Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 65: European Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 66: European Market Shares for Advanced Drug Delivery Systems, by Country, 2024
Figure 67: German Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 68: German Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 69: German Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 70: German Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 71: U.K. Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 72: U.K. Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 73: U.K. Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 74: U.K. Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 75: French Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 76: French Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 77: French Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 78: French Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 79: Italian Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 80: Italian Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 81: Italian Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 82: Italian Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 83: Spanish Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 84: Spanish Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 85: Spanish Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 86: Spanish Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 87: Rest of Europe Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 88: Rest of Europe Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 89: Rest of Europe Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 90: Rest of Europe Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 91: Asia-Pacific Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 92: Asia-Pacific Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 93: Asia-Pacific Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 94: Asia-Pacific Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 95: Asia-Pacific Market Shares for Advanced Drug Delivery Systems, by Country, 2024
Figure 96: Chinese Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 97: Chinese Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 98: Chinese Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 99: Chinese Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 100: Japanese Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 101: Japanese Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 102: Japanese Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 103: Japanese Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 104: Indian Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 105: Indian Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 106: Indian Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 107: Indian Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 108: South Korean Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 109: South Korean Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 110: South Korean Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 111: South Korean Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 112: Australian Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 113: Australian Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 114: Australian Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 115: Australian Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 116: Rest of Asia-Pacific Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 117: Rest of Asia-Pacific Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 118: Rest of Asia-Pacific Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 119: Rest of Asia-Pacific Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 120: MEA Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 121: MEA Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 122: MEA Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 123: MEA Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 124: MEA Market Shares for Advanced Drug Delivery Systems, by Sub-Region, 2024
Figure 125: Middle East Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 126: Middle East Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 127: Middle East Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 128: Middle East Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 129: African Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 130: African Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 131: African Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 132: African Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 133: South American Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 134: South American Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 135: South American Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 136: South American Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 137: South American Market Shares for Advanced Drug Delivery Systems, by Country, 2024
Figure 138: Brazilian Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 139: Brazilian Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 140: Brazilian Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 141: Brazilian Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 142: Argentinian Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 143: Argentinian Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 144: Argentinian Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 145: Argentinian Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 146: Rest of South America Market Shares for Advanced Drug Delivery Systems, by Route of Administration, 2024
Figure 147: Rest of South America Market Shares for Advanced Drug Delivery Systems, by Technology, 2024
Figure 148: Rest of South America Market Shares for Advanced Drug Delivery Systems, by Vehicle/Carrier, 2024
Figure 149: Rest of South America Market Shares for Advanced Drug Delivery Systems, by Application, 2024
Figure 150: Leading 10 Advanced Drug Delivery Systems, by Sales Revenue, 2023-2024
Figure 151: Global Market Shares for Advanced Drug Delivery Systems, by Company, 2024
Figure 152: Pillars of ESG
Figure 153: Advantages of ESG for Companies
Figure 154: Abbott: Revenue Share, by Business Unit, FY 2024
Figure 155: Abbott: Revenue Share, by Country/Region, FY 2024
Figure 156: AbbVie Inc.: Revenue Share, by Business Unit, FY 2024
Figure 157: AbbVie Inc.: Revenue Share, by Country/Region, FY 2024
Figure 158: Amgen Inc.: Revenue Share, by Business Unit, FY 2024
Figure 159: Amgen Inc.: Revenue Share, by Country/Region, FY 2024
Figure 160: AstraZeneca: Revenue Share, by Business Unit, FY 2024
Figure 161: AstraZeneca: Revenue Share, by Country/Region, FY 2024
Figure 162: Baxter: Revenue Share, by Business Unit, FY 2024
Figure 163: Baxter: Revenue Share, by Country/Region, FY 2024
Figure 164: Bayer AG: Revenue Share, by Business Unit, FY 2024
Figure 165: Bayer AG: Revenue Share, by Country/Region, FY 2024
Figure 166: Boston Scientific Corp.: Revenue Share, by Business Unit, FY 2024
Figure 167: Boston Scientific Corp.: Revenue Share, by Country/Region, FY 2024
Figure 168: Bristol-Myers Squibb Co.: Revenue Share, by Business Unit, FY 2024
Figure 169: Bristol-Myers Squibb Co.: Revenue Share, by Country/Region, FY 2024
Figure 170: F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2024
Figure 171: F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2024
Figure 172: Gilead Sciences Inc.: Revenue Share, by Business Unit, FY 2024
Figure 173: Gilead Sciences Inc.: Revenue Share, by Country/Region, FY 2024
Figure 174: GSK plc: Revenue Share, by Business Unit, FY 2024
Figure 175: GSK plc: Revenue Share, by Country/Region, FY 2024
Figure 176: Jazz Pharmaceuticals Inc.: Revenue Share, by Business Unit, FY 2024
Figure 177: Jazz Pharmaceuticals Inc.: Revenue Share, by Country/Region, FY 2024
Figure 178: Johnson & Johnson: Revenue Share, by Business Unit, FY 2024
Figure 179: Johnson & Johnson: Revenue Share, by Country/Region, FY 2024
Figure 180: Merck & Co. Inc.: Revenue Share, by Business Unit, FY 2024
Figure 181: Merck & Co. Inc.: Revenue Share, by Country/Region, FY 2024
Figure 182: Novartis AG: Revenue Share, by Business Unit, FY 2024
Figure 183: Novartis AG: Revenue Share, by Country/Region, FY 2024
Figure 184: Pfizer Inc.: Revenue Share, by Business Unit, FY 2024
Figure 185: Pfizer Inc.: Revenue Share, by Country/Region, FY 2024
Figure 186: Sanofi: Revenue Share, by Country/Region, FY 2024
Companies Mentioned
- Abbott
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca
- Baxter
- Bayer AG
- Boston Scientific Corp.
- Bristol-Myers Squibb Co.
- F. Hoffmann-La Roche Ltd.
- Gilead Sciences Inc.
- GSK plc
- Jazz Pharmaceuticals Inc.
- Johnson & Johnson
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 339 |
| Published | December 2025 |
| Forecast Period | 2025 - 2030 |
| Estimated Market Value ( USD | $ 299.6 Billion |
| Forecasted Market Value ( USD | $ 487.4 Billion |
| Compound Annual Growth Rate | 10.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
